1. Better quality of life and reduced fecal incontinence in rectal cancer patients with the watch-and-wait follow-up strategy
- Author
-
A. Pascual-Russo, D. Milito, L. Facio, M. Furia, V. Forestier, S. Iseas, G. Méndez, M. Coraglio, C.M. Lumi, G. Masciangioli, E. Mauriño, and H. Vázquez
- Subjects
Cáncer de recto ,Calidad de vida ,Trastornos funcionales anorrectales ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introduction: The watch-and-wait (WW) strategy is an alternative to anterior resection in patients with rectal cancer (RC) that have had a complete clinical response to neoadjuvant treatment. Few reports describe the quality of life and functional anorectal disorders (FADs) in that population. Aim: To analyze and compare the FADs and quality of life in patients with locally advanced adenocarcinoma of the rectum treated with neoadjuvant therapy, divided into two different strategy groups: group 1 (G1), WW; and group 2 (G2), anterior resection. Materials and methods: Thirty patients (G1: n = 20 and G2: n = 10) that had finished neoadjuvant therapy at least 12 months prior were included. Mean patient age was 59.5 years (range: 41-79) and 15 of the patients were men. The FADs were evaluated through: a) clinical history, b) 21-day bowel diary, c) Jorge and Wexner fecal incontinence scale, d) anorectal manometry (ARM), and fecal incontinence quality of life scale (FIQL). Results: Bowel diary: fecal incontinence (40%) and urge to defecate (45%) in G1 vs. fecal incontinence (60%) and urge to defecate (30%) in G2, with no significant differences (p = NS). Fecal incontinence scale: fecal incontinence in G1 was significantly less severe than that in G2 (median 6.5 points vs. 13 points [p = 0.0142]). ARM: no differences between the two groups. Quality of life: significantly different between the two groups (FIQL/G1: 3.7 vs. FIQL/G2: 2.8; p
- Published
- 2021
- Full Text
- View/download PDF